Ulisse Biomed Logo

Ulisse Biomed

Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.

UBM | XMIL

Overview

Corporate Details

ISIN(s):
IT0005451213 (+1 more)
LEI:
815600F9C180B297BE35
Country:
Italy
Address:
VIA AQUILEIA, 17, 33100 UDINE
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ulisse Biomed is a global biotechnology company focused on decentralizing genetic analysis and diagnostics. Its core offering is the proprietary Hyris System™, a portable, smart platform that enables rapid real-time PCR testing of biological samples in any setting. By making genetic analysis simpler and more accessible, the company facilitates the shift from centralized laboratories to point-of-need applications. Ulisse Biomed serves clients in the healthcare, diagnostics, agrifood, and nutraceutical sectors. Additionally, it provides OEM and development services for third-party kit developers and is engaged in creating innovative theranostic and therapeutic solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 17:55
Share Issue/Capital Change
CHIUSURA OTTAVO PERIODO DI ESERCIZIO WARRANT
Italian 222.3 KB
2025-09-30 18:02
Share Issue/Capital Change
APERTURA DELL’OTTAVO PERIODO DI ESERCIZIO DEI “WARRANT ULISSE BIOMED S.P.A. 202…
Italian 208.5 KB
2025-09-30 17:54
Report Publication Announcement
IL CONSIGLIO DI AMMINISTRAZIONE DI ULISSE BIOMED APPROVA LA RELAZIONE SEMESTRAL…
Italian 683.5 KB
2025-09-05 20:05
Regulatory News Service
ULISSE BIOMED S.P.A. INDIVIDUA BANCA FINNAT COME INTERMEDIARIO PER LA NEGOZIAZI…
Italian 207.5 KB
2025-07-31 19:58
Share Issue/Capital Change
SIGNED AN INVESTMENT AGREEMENT WITH U.S. INVESTOR GLOBAL CORPORATE FINANCE
English 323.4 KB
2025-07-31 19:37
Share Issue/Capital Change
SOTTOSCRITTO UN ACCORDO DI INVESTIMENTO CON L’INVESTITORE STATUNITENSE GLOBAL C…
Italian 540.4 KB
2025-07-23 18:37
Share Issue/Capital Change
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
Italian 255.4 KB
2025-06-30 17:38
Share Issue/Capital Change
“WARRANT ULISSE BIOMED S.P.A. 2021-2026”: RISULTATI DEL SETTIMO PERIODO DI ESER…
Italian 241.8 KB
2025-05-30 12:21
Share Issue/Capital Change
APERTURA DEL SETTIMO PERIODO DI ESERCIZIO DEI “WARRANT ULISSE BIOMED S.P.A. 202…
Italian 188.9 KB
2025-05-12 12:02
Report Publication Announcement
WEBSIM INIZIA LA COPERTURA DEL TITOLO UBM
Italian 181.7 KB
2025-04-28 16:36
Pre-Annual General Meeting Information
RINVIO ASSEMBLEA ORDINARIA E STRAORDINARIA IN SECONDA CONVOCAZIONE
Italian 181.0 KB
2025-04-12 14:07
Pre-Annual General Meeting Information
CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI E DEPOSIT…
Italian 203.8 KB
2025-03-28 21:22
Annual / Quarterly Financial Statement
IL CONSIGLIO DI AMMINISTRAZIONE DI ULISSE BIOMED APPROVA IL PROGETTO DI BILANCI…
Italian 488.4 KB
2025-03-12 06:50
Regulatory News Service
AVVIO DELLA SECONDA FASE DEL PROGETTO DI SVILUPPO PER LA LOTTA CONTRO LA MALARIA
Italian 185.7 KB
2025-02-14 17:43
Share Issue/Capital Change
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
Italian 250.9 KB

Automate Your Workflow. Get a real-time feed of all Ulisse Biomed filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ulisse Biomed

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ulisse Biomed via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
Adagio Medical Holdings, Inc. Logo
Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.
United States of America ADGM
Advanced Biomed Inc. Logo
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
AETHLON MEDICAL INC Logo
Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.
United States of America AEMD
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America AIMD
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690

Talk to a Data Expert

Have a question? We'll get back to you promptly.